BioRegen Biomedical (Changzhou) Co., Ltd.
PrivateLast Round
IPO
Jul 3, 2026
Total Funding Raised
$7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
BioRegen Biomedical (Changzhou) Co., Ltd. is a medical device company that develops and manufactures therapeutic biomaterials and regenerative medicine products, including hyaluronic acid-based gels for surgical applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioRegen Biomedical (Changzhou) Co., Ltd. Comparables
Compare BioRegen Biomedical (Changzhou) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Beijing Bestlife Regenerative Medicine Technology Co., Ltd. | 88% | |
| Hangzhou Singclean Medical Products Co., Ltd. | 82% | |
| Shanghai Haohai Biological Technology Co. Ltd | 81% | |
BioRegen Biomedical (Changzhou) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Jul 3, 2026 | ||||
| Strategic | Feb 1, 2021 | ||||
| Series D | Jun 1, 2016 | ||||
| Series C | Jun 7, 2013 | ||||
| Series B | Jan 1, 2011 | ||||
Series A | Dec 1, 2008 |
BioRegen Biomedical (Changzhou) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Orient Securities Capital Investment Company | Strategic |
| F-Prime Capital | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 3, 2026
$15.14M raised in IPO round.
- Apr 11, 2026
Grew 57% QoQ from 7 to 11 employees.
BioRegen Biomedical (Changzhou) Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioRegen Biomedical (Changzhou) Co., Ltd.'s valuation, stock price, and market status.